-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MmqOjMlOjKtpmEmPAC8BN15VSJtxcoCQBnasfDtuj1U4GrgImNAK9qZNnKYBX1G/ uJ/0iQO82qzMJqn9e2jxyw== 0001021890-00-000076.txt : 20000310 0001021890-00-000076.hdr.sgml : 20000310 ACCESSION NUMBER: 0001021890-00-000076 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000309 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: URANIUM POWER CORP CENTRAL INDEX KEY: 0001096791 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS METAL ORES [1090] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-58657 FILM NUMBER: 563987 BUSINESS ADDRESS: STREET 1: 206-475 HOWE ST STREET 2: V6C 2B3 CITY: VANCOUVER BC BUSINESS PHONE: 6046858355 MAIL ADDRESS: STREET 1: 206-475 HOWE ST STREET 2: V6C 2B3 CITY: VANCOUVER BC FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SMITH MARK T CENTRAL INDEX KEY: 0001102808 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 7670 FIRST PLACE CITY: OAKWOOD STATE: OH ZIP: 44146 BUSINESS PHONE: 4403590000 MAIL ADDRESS: STREET 1: 7670 FIRST PLACE CITY: OAKWOOD STATE: OH ZIP: 44146 SC 13D 1 SCHEDULE 13D SEC Potential persons who are to respond to the collection of information 1746 contained in this form are not required to respond unless the form (2-98) displays a currently valid OMB control number. ------------------------------------------- OMB APPROVAL ------------------------------------------- OMB Number: 3235-0145 Expires: November 30, 1999 Estimated average burden hours per form................... ------------------------------------------- UNITED STAES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.____________)* Uranium Power Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 917022105 - -------------------------------------------------------------------------------- (CUSIP Number) Theresa M. Mehringer, Esq., c/o Smith McCullough, P.C. 4643 S. Ulster Street, Suite 900, Denver, Colorado 80237 (303) 221-6000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 12/13/99 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) CUSIP No. 917022105 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only) Mark T. Smith - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES 600,000 BENEFICIALLY -------------------------------------------------------------- OWNED BY 8 SHARED VOTING POWER EACH 0 REPORTING -------------------------------------------------------------- PERSON 9 SOLE DISPOSITIVE POWER WITH 600,000 -------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 -------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 600,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.7% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- 2 Item 1. Security and Issuer Common Stock, $.001 par value per share Uranium Power Corporation 206 - 475 Howe Street Vancouver, British Columbia Canada V6C 2B3 Item 2. Identity and Background (a) The Reporting Person is Mark T. Smith (b) The residence address of the Reporting Person is: 5090 Warwick Terrace Pittsburgh, PA 15213 (c) The principal occupation of the Reporting Person is: Pharmaceutical Company President The principal business address of the Reporting Person's employer is: Oakwood Laboratories LLC 7670 First Place Oakwood, OH 44146 (d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which the Reporting Person was or is subject to a judgement, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration The Reporting Person acquired 600,000 shares of the Issuer from the Issuer in a private placement on December 8, 1999. The source of the funds for the purchase was personal funds. 3 Item 4 Purpose of Transaction The Reporting Person acquired the Issuer's securities for investment purposes. The Reporting Person has no plans at this time to acquire additional shares of the Issuer, or to dispose of shares of the Issuer. Item 5 Interest in the Securities of the Issuer (a) The Reporting Person directly owns 600,000 shares, resulting in beneficial ownership by the Reporting Person of an aggregate of 600,000 shares, representing approximately 8.7% of the Issuer's outstanding common stock as of March 3, 2000. (b) The Reporting Person has the sole power to vote, direct the vote of, dispose of and direct the disposition of 600,000 shares of common stock. (c) No transactions in the Issuer's common stock have been effected in the last 60 days by the reporting Person. (d) No other person has rights with respect to the securities beneficially owned by the Reporting Person. (e) Not Applicable. Item 6 Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer. None Item 7. Material to be Filed as Exhibits None Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 3, 2000 /s/ Mark T. Smith ------------------------------------- Mark T. Smith 4 -----END PRIVACY-ENHANCED MESSAGE-----